Viewing Study NCT04560166


Ignite Creation Date: 2025-12-24 @ 4:36 PM
Ignite Modification Date: 2025-12-29 @ 8:43 PM
Study NCT ID: NCT04560166
Status: TERMINATED
Last Update Posted: 2024-03-18
First Post: 2020-09-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Naxitamab and GM-CSF in Combination With IT in Patients With High-Risk Neuroblastoma
Sponsor: Y-mAbs Therapeutics
Organization: